Coffee Therapy for Hepatitis C?

Drinking 3 cups of coffee a day helps patients with hepatitis C respond to treatment, report Neal Freedman et al. in the June issue of Gastroenterology. Coffee reduces risks of progression of liver diseases and risk for hepatocellular carcinoma, so Freedman et al. investigated whether it also had benefits for patients

Read more

Tracking Crohn’s Therapy

Measuring blood levels of C-reactive protein (CRP), a marker of inflammation, is a good way to monitor recovery from Crohn’s disease (CD) in patients being treated with infliximab, according to Matthias Jürgens et al. in the May issue of Clinical Gastroenterology and Hepatology. CRP is a protein released into the blood

Read more

New Word on GERD?

Proton pump inhibitors (PPIs) are useful for treating gastroesophageal reflux disease (GERD), although heartburn completely resolves in only 40% of patients that take these drugs. Furthermore, long-term use of PPIs can increase risk for pneumonia, Clostridium difficile infection, and bone disorders, so other therapeutic strategies are needed. In the August

Read more

Curbing Crohn’s for the Long Term?

Most people with Crohn’s disease receive surgery, yet the disease comes back a short time later. A study in the July issue of Clinical Gastroenterology and Hepatology reports that giving patients low doses of infliximab immediately after surgery prevents disease recurrence over long time periods. Dario Sorrentino et al. began

Read more